• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Signal Transduct Target Ther . Ninjurin-1 mediates cell lysis and detrimental inflammation of PANoptosis during influenza A virus infection

tetano

Editor, Senior Moderator
Signal Transduct Target Ther


. 2025 Sep 23;10(1):307.
doi: 10.1038/s41392-025-02391-9. Ninjurin-1 mediates cell lysis and detrimental inflammation of PANoptosis during influenza A virus infection

Yitian Xu[SUP] #[/SUP][SUP] 1 2 [/SUP], Ying Zheng[SUP] #[/SUP][SUP] 2 3 [/SUP], Yan Liu[SUP] #[/SUP][SUP] 4 [/SUP], Cheng Wei[SUP] #[/SUP][SUP] 2 [/SUP], Juan Ren[SUP] 2 5 [/SUP], Wenting Zuo[SUP] 1 2 [/SUP], Runqing Gu[SUP] 6 [/SUP], Hongyu Liu[SUP] 2 3 [/SUP], Xiaoyan Deng[SUP] 7 [/SUP], Yaxue Liu[SUP] 8 [/SUP], Xiao Shang[SUP] 8 [/SUP], Weiwei Ge[SUP] 7 [/SUP], Ziyao Li[SUP] 2 [/SUP], Yijiao Huang[SUP] 8 [/SUP], Di He[SUP] 2 3 [/SUP], Xuhui Shen[SUP] 2 [/SUP], Zeyi Wang[SUP] 2 [/SUP], Chen Lyu[SUP] 1 2 [/SUP], Zai Wang[SUP] 2 [/SUP], Yuxian Mu[SUP] 1 2 [/SUP], Zihuan Zhang[SUP] 1 [/SUP], Hongping Wu[SUP] 9 [/SUP], Haibo Li[SUP] 10 [/SUP], Bin Cao[SUP] 11 12 13 14 15 [/SUP]



Affiliations
Abstract

Influenza A virus (IAV) induces ZBP1-mediated PANoptosis, a form of lytic inflammatory cell death characterized by concurrent activation of the pyroptosis, necroptosis and apoptosis pathways. Ninjurin-1 (NINJ1) is a recently identified mediator of plasma membrane rupture but functions diversely in different types of cell death. However, little is known about the role of NINJ1 in IAV-induced PANoptosis and viral pneumonia. Here, we report that IAV infection triggered an increase in the expression of NINJ1, which then oligomerized and mediated cell lysis in infected macrophages. The deficiency of NINJ1 prevented plasma membrane rupture and the release of DAMPs and IL-1β without affecting the progression of cell death. Activation of any single PANoptosis pathway was sufficient to trigger the oligomerization of NINJ1 and robust cell lysis. Accordingly, only when all PANoptosis pathways were concurrently blocked could the oligomerization of NINJ1, cell death, and cell rupture be prevented. Ablation of NINJ1 in vivo also alleviated IAV-induced lung injury and mortality. Furthermore, we revealed an association between NINJ1 upregulation and poor outcomes in patients with COVID-19. Collectively, our findings indicate a pivotal role of NINJ1 in the immunopathology of IAV infection and its potential as a bioindicator of disease severity and prognosis in viral pneumonia and viral sepsis.


 
Back
Top